NCT00330395View on ClinicalTrials.gov

Open, Pharmacokinetic Study of Caspofungin in Neonates and Infants (0991-058)

PHASE2CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

October 31, 2006

Study Completion Date

October 31, 2006

Conditions
Candidiasis
Interventions
DRUG

caspofungin acetate

Duration of Treatment 28 Days

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00330395 - Open, Pharmacokinetic Study of Caspofungin in Neonates and Infants (0991-058) | Biotech Hunter | Biotech Hunter